Gary Frazier, Chief Growth Officer at Helio Genomics
What You Should Know:
– Helio Genomics, an AI-driven healthcare company specializing in diagnostics technology for cancer detection, has appointed Gary Frazier as its Chief Growth Officer.
– Frazier’s…
Continue Reading
SimonMed, a leading outpatient medical imaging provider, has harnessed artificial intelligence (AI) to revolutionize radiology processes. With an 82% reduction in report turnaround time and a sensitivity range of 96.9% to 100% per bone,…
Continue Reading
Welcome to the January edition of Digital Health Digest on our YouTube channel! Dive into the latest and most exciting advancements in digital healthcare, from cutting-edge diagnostic tools to innovative telehealth services. In this…
Continue Reading
Riverrain’s ClearRead CT technology, chosen by the U.S. Department of Veterans Affairs, is transforming lung cancer diagnostics for nearly 8,000 veterans annually. The software’s AI-powered precision measurements promise consistency, alleviating radiology burnout and talent…
Continue Reading
The finalists of the most eye-catching UK digital health start-up competition have been unveiled ahead of the live final at Digital Health Rewired 2024 in March at The NEC in Birmingham.After a hard-fought set…
Continue Reading
Rural-focused e-clinics chain CureBay scored another Rs 620 million ($7.5 million) in funding as part of a Series A round led by Elevar Equity. This comes on top of the first $6 million it raised…
Continue Reading
The healthcare sector witnessed a significant transformation in 2023, largely driven by the integration of artificial intelligence (AI) in patient diagnostics. This integration marks a revolutionary step in how medical professionals approach diagnosis, offering…
Continue Reading
Investment trends panel discussion, INVEST 2022. From L-R: Christina Jenkins, venture partner, Phoenix Venture Partners; Michael Yang, managing partner, Omers Ventures; Alyssa Jaffee, partner, 7wireVentures; Daniel Lubienietzky, manager of life sciences, TMX Group.
The MedCity…
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of Wisconsin Investment Board (SWIB) led the…
Continue Reading
b-rayZ proudly secures the CE mark for DANAI, an industry-first Custom AI technology embedded in the b-box plus suite. DANAI, set to launch at ECR 2024, dynamically adapts to diverse clinical environments, enhancing diagnostic…
Continue Reading
